Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease

International Journal of Cardiology

Volumn 184, Issue 1, 2015, Pages 108-114

  Rohla, Miklos ^a   Vennekate, Christoph Kleine ^a   Tentzeris, Ioannis ^a   Freynhofer, Matthias K ^a   Farhan, Serdar ^a   Egger, Florian ^a   Weiss, Thomas W ^a   Wojta, Johann ^b   Granger, Christopher B ^c   Huber, Kurt ^a  

^a WILHELMINEN HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antithrombotic therapy; Atrial fibrillation; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PHENPROCOUMON; PRASUGREL; TICAGRELOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; BRAIN ISCHEMIA; CLINICAL CLASSIFICATION; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENTING; DRUG INDICATION; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SINUS RHYTHM; STABLE CORONARY ARTERY DISEASE; THROMBOSIS; COHORT ANALYSIS; MIDDLE AGED; REGISTER; RISK FACTOR; STENT; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; REGISTRIES; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 84934276600     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.02.004     Document Type: Article

References (25)

1. A.S. Go, E.M. Hylek, K.A. Phillips, Y. Chang, L.E. Henault, J.V. Selby, et al., Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythmmanagement and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study, JAMA 285 (2001) 2370-2375.
2. J. Schmitt, G. Duray, B.J. Gersh, S.H. Hohnloser, Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications, Eur. Heart J. 30 (2009) 1038-1045.
3. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, M.J. Blaha, et al., Heart disease and stroke statistics-2014 update: A report from the american heart association, Circulation 129 (2014) e28-e292.
4. M.L. Hansen, R. Sorensen, M.T. Clausen, M.L. Fog-Petersen, J. Raunso, N. Gadsboll, et al., Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation, Arch. Intern. Med. 170 (2010) 1433-1441.
5. M. Langenberg, B.S. Hellemons, J.W. van Ree, F. Vermeer, J. Lodder, H.J. Schouten, et al., Atrial fibrillation in elderly patients: Prevalence and comorbidity in general practice, BMJ 313 (1996) 1534.
6. J.M. Ruiz-Nodar, F.Marin, J.A. Hurtado, J. Valencia, E. Pinar, J. Pineda, et al., Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis, J. Am. Coll. Cardiol. 51 (2008) 818-825.
7. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, et al., Guidelines for themanagement of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur. Heart J. 31 (2010) 2369-2429.
8. G.Y. Lip, K. Huber, F. Andreotti, H. Arnesen, K.J. Airaksinen, T. Cuisset, et al., Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting, Thromb. Haemost. 103 (2010) 13-28.
9. G.Y. Lip, M. Karpha, Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: The need for consensus and a management guideline, Chest 130 (2006) 1823-1827.
10. R.D. Lopes, L.E. Elliott, H.D. White, J.S. Hochman, F. Van de Werf, D. Ardissino, et al., Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: Results from the APEX-AMI trial, Eur. Heart J. 30 (2009) 2019-2028.
11. M. Almendro-Delia, M.J. Valle-Caballero, J.C. Garcia-Rubira, B. Munoz-Calero, A. Garcia-Alcantara, A. Reina-Toral, et al., Prognostic impact of atrial fibrillation in acute coronary syndromes: Results from the ARIAM registry, Eur. Heart J. Acute Cardiovasc. Care 3 (2) (Jun 2014) 141-148.
12. P. Bramlage, A. Cuneo, U. Zeymer,M. Hochadel, G. Richardt, S. Silber, et al., Prognosis of patients with atrial fibrillation undergoing percutaneous coronary intervention receiving drug eluting stents, Clin. Res. Cardiol. 102 (2013) 289-297.
13. R.D. Lopes, K.S. Pieper, J.R. Horton, S.M. Al-Khatib, L.K. Newby, R.H. Mehta, et al., Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation, Heart 94 (2008) 867-873.
14. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, et al., Dabigatran versus warfarin in patients with atrial fibrillation, N. Engl. J. Med. 361 (2009) 1139-1151.
15. C.B. Granger, J.H. Alexander, J.J. McMurray, R.D. Lopes, E.M. Hylek, M. Hanna, et al., Apixaban versus warfarin in patients with atrial fibrillation, N. Engl. J. Med. 365 (2011) 981-992.
16. M.R. Patel,K.W.Mahaffey, J.Garg,G. Pan,D.E. Singer,W. Hacke, et al., Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N. Engl. J. Med. 365 (2011) 883-891.
17. R.G. Hart, L.A. Pearce, M.I. Aguilar, Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann. Intern. Med. 146 (2007) 857-867.
18. C.T. Ruff, R.P. Giugliano, E. Braunwald, E.B. Hoffman, N. Deenadayalu, M.D. Ezekowitz, et al., Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials, Lancet 383 (2014) 955-962.
19. F. Angeli, G. Reboldi,M. Garofoli, E. Ramundo, C. Poltronieri, G. Mazzotta, et al., Atrial fibrillation and mortality in patients with acute myocardial infarction: A systematic overview and meta-analysis, Curr. Cardiol. Rep. 14 (2012) 601-610.
20. P. Jabre, V.L. Roger,M.H. Murad, A.M. Chamberlain, L. Prokop, F. Adnet, et al.,Mortality associated with atrial fibrillation in patients with myocardial infarction: A systematic review and meta-analysis, Circulation 123 (2011) 1587-1593.
21. K.Kinjo,H. Sato, H. Sato,Y.Ohnishi,E.Hishida,D.Nakatani, et al., Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention, Am. J. Cardiol. 92 (2003) 1150-1154.
22. M.M. El-Omar, G. Dangas, R. Mehran, A.J. Lansky, N.N. Kipshidze, S. Polena, et al., Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary intervention, Am. J. Cardiol. 91 (2003) 232-234.
23. E.M. Hylek, A.S. Go, Y. Chang, N.G. Jensvold, L.E. Henault, J.V. Selby, et al., Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation, N. Engl. J. Med. 349 (2003) 1019-1026.
24. F. Pizzetti, F.M. Turazza, M.G. Franzosi, S. Barlera, A. Ledda, A.P.Maggioni, et al., Incidence and prognostic significance of atrial fibrillation in acutemyocardial infarction: The GISSI-3 data, Heart 86 (2001) 527-532.
25. E.J. Benjamin, P.A.Wolf, R.B. D'Agostino, H. Silbershatz,W.B. Kannel, D. Levy, Impact of atrial fibrillation on the risk of death: The Framingham Heart Study, Circulation 98 (1998) 946-952.